BLTE Q2 2022 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena

BLTEBelite Bio, Inc

$7B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$2M

EPS (Diluted)

$-0.12

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$51M

Total Liabilities

$1M

Stockholders' Equity

$50M

Cash & Equivalents

$48,700

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$2M	-4.5%
Net Income	-$2M	-$2M	-1.3%